Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.

Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Abstract Text:

    prajnan dasPrajnan Das,john m skibberJohn M Skibber,miguel a rodriguez-bigasMiguel A Rodriguez-Bigas,barry w feigBarry W Feig,george j changGeorge J Chang,robert a wolffRobert A Wolff,cathy engCathy Eng,sunil krishnanSunil Krishnan,nora a janjanNora A Janjan,christopher h craneChristopher H Crane,

    BACKGROUND: The objective of this study was to identify predictive factors for pathologic complete response and tumor downstaging after preoperative chemoradiation for rectal cancer. METHODS: Between 1989 and 2004, 562 patients with nonmetastatic rectal adenocarcinoma received preoperative chemoradiation and underwent mesorectal excision. The median radiation dose was 45 Gray (Gy) (range, 19.8-58.6 Gy), 77% of patients received concurrent infusional 5-fluorouracil, 20% of patients received concurrent capecitabine, and 3% of patients received other regimens. RESULTS: Nineteen percent of patients achieved a pathologic complete response (CR), whereas 20% of patients had only microscopic residual disease at surgery, and 61% of patients had macroscopic residual disease at surgery. Downstaging of the tumor stage occurred in 57% of patients. The results from a univariate analysis indicated that tumor circumferential extent>60% (P=.033) and pretreatment carcinoembryonic antigen (CEA) level>2.5 ng/mL (P=.015) were associated significantly with lower pathologic CR rates. The univariate analysis also indicated that tumor circumferential extent>60% (P=.001), pretreatment CEA level>2.5 ng/mL (P=.006), and distance from the anal verge>5 cm (P=.035) were associated significantly with lower downstaging rates. The results from a multivariate logistic regression analysis indicated that greater circumferential extent of tumor (odds ratio [OR], 0.43; P=.033) independently predicted a lower pathologic CR rate. The multivariate logistic regression analysis also indicated that greater circumferential extent of tumor (OR, 0.49; P=.020) and greater distance from the anal verge (OR, 0.46; P=.010) independently predicted a lower downstaging rate. CONCLUSIONS: Circumferential extent of tumor, CEA level, and distance from the anal verge predicted for the pathologic response to preoperative chemoradiation for patients with rectal cancer. Therefore, these factors may be used to predict outcomes for patients, to develop risk-adapted treatment strategies, and to target patients who participate in trials of newer therapies.

    Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Publishing Authors By Initials

    p dasP Das,jm skibberJM Skibber,ma rodriguez-bigasMA Rodriguez-Bigas,bw feigBW Feig,gj changGJ Chang,ra wolffRA Wolff,c engC Eng,s krishnanS Krishnan,na janjanNA Janjan,ch craneCH Crane,

    For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Cancer

    VOLUME: 109

    Page Numbers: 1750-5

    Journal Abbreviation: Cancer

    ISSN: 0008-543X

    DAY: 1

    MONTH: May

    YEAR: 2007

    Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 374236

    Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Keywords Mesh Terms:

    KEYWORDS: Treatment Outcome

    MESH TERMS: therapy

    Chemical & Substance for Abstract: Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Information

    Substance Name: Carcinoembryonic Antigen

    Registry Number: 0

    Grant and Affiliation Information for Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.

    AFFILIATION: Department of Radiation Oncology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. prajdas@mdanderson.org

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: CA06294

    ACRONYM: CA

    MEDLINETA: Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News